MEDIFACTS Announces $1.9 Million Study Award with Global Pharmaceutical Company
ROCKVILLE, Md. & LANGENFELD, Germany-(Business Wire)-September 22, 2009 - MEDIFACTS INTERNATIONAL, INC., one of the largest global providers of noninvasive cardiac diagnostic services, today announced the award of a $1.9 million contract with a Global pharmaceutical company to provide comprehensive cardiac safety and efficacy services for a large late stage clinical trial.
Demonstrating a unique ability to combine multiple technology platforms and innovative and efficient study design in one offering, Medifacts will provide consulting, equipment and an array of services for a cardiac safety study set across 180 sites worldwide.
Michael Woehler, Medifacts International’s President and Chief Executive Officer, said: "We are excited the industry continues to recognize the superior quality of Medifacts’ global services and entrust us with their key programs. Medifacts and our WebHeart® platform continue to set the global standard in cardiac safety and efficacy data collection, management and submission. Medifacts International’s commitment to our sponsors’ rigorous expectations continues to pay dividends as we advance our position as one of the top 3 global cardiac safety businesses.”
About MEDIFACTS
Driven by best-in-class Science, Technology, and Service Quality, Medifacts International has become a global leader providing ECG, Holter, Ambulatory Blood Pressure Monitoring, Spirometry, Glucometry, Pulse Wave Analysis and related services to pharmaceutical, biotech and medical device companies.
Medifacts International’s scientific expertise, proprietary WebHeart® technology, global presence and recognized quality leadership has established Medifacts International as one of the top 3 providers in comprehensive cardiac safety and efficacy services.
WebHeart® is a proprietary, global, web-based platform that offers a complete solution to acquiring, displaying, measuring, and managing cardiac safety and efficacy data in clinical trials. This system allows for live, genuine real-time access to ongoing study activity and data, delivering value added services to Medifacts International’s clients alongside operational and cost efficiencies. Because no actual programming is needed, the time and cost of both study setup and data submission are dramatically reduced.
 |
 |
 |
|
||
 |
|
 |
|
||
Search Our News Using Google Search
Can't find what you want? Try using Google:
